September 21, 2022
Three drug manufacturers for Viatris have urged a Pennsylvania federal judge to cut them loose from a patent suit lodged by a Johnson & Johnson branch over a generic multiple sclerosis treatment, arguing that the court lacks jurisdiction and the overseas suppliers can't be held liable for the allegedly infringing products.
May 24, 2022
Mylan has been using Momenta's patented manufacturing methods to make a generic version of a multiple sclerosis treatment, the Johnson & Johnson unit alleged in a new infringement lawsuit in Pennsylvania federal court.